TP05 for the Treatment of Mild to Moderate Active Ulcerative Colitis (UC)

Clinical trial NCT01903252 · COMPLETED

Trial details

NCT number: NCT01903252
Sponsor: Tillotts Pharma AG
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Acute Ulcerative Colitis

Start date: 2013-07-01
Primary completion: 2016-05-01
Enrollment: 817

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.